In stage I and II ovarian cancer patients with a high CTCFL mRNA expression displayed a worse OS compared with counterparts with low CTCF mRNA expression (HR = 2.66, 95% CI = 1.3–5.46, p = 0.0055, not shown). The gene discussed is CTCF; the disease is ovarian cancer.